-
MBI Seminar: David Mangelsdorf, Ph.D.
MBI Seminar: David Mangelsdorf, Ph.D.
Investigator, Howard Hughes Medical Institute Professor & Alfred G. Gilman Distinguished Chair in Pharmacology Raymond & Ellen Willie Distinguished Chair in Molecular Neuropharmacology in Honor of Harold B. Crasilneck, Ph.D. Department of Pharmacology & Biochemistry, UT Southwestern Medical Center “The Diverse Metabolic Actions of FGF21” Mangelsdorf Lab Hosted by Tom Vallim, Ph.D., tvallim@mednet.ucla.edu